This application is for the continuation of the existing Partnership beWveen Morehouse School of Medicine (MSM), Tuskegee University (TU), and the UAB Comprehensive Cancer Center (UABCCC). The Partnership, located in the heart ofthe Southeast, a region with a large, historically underserved African American population, has goals of attaining excellence in research focused on the basis of cancer health disparities and on reducing the cancer burden. All three institutions, w/hich are assisting underserved communities, possess unique strengths that supplement each other. The primary objectives are to maintain progress in establishing productive cancer research programs at MSM and TU and to persist in developing a pipeline of prospective minority investigators at TU. The Partnership has three Cores (Administrative, Planning &Evaluation, and Developmental). Within the Developmental Core, there are four Research Programs and two Shared Resources (Bioethics and Biostatistics). With the Research Programs, the Partnership will continue: 1) to tap the pool of talented students and faculty at MSM and TU through the Research Training and Career Development (RTCD) Program, linking them to established Investigators and to the research infrastructure at the UABCCC;2) to promote a Developmental Research (DR) Program, which provides funding for research projects;3) to encourage graduate and undergraduate students across various scientific disciplines to pursue careers in the biosciences through our Cancer Education Program and to provide a pipeline into our RTCD and DR Programs;and 4) to promote cancer awareness and healthy lifestyles among our underserved populations and increase minority participation in therapeutic clinical trails our established Community Outreach Program. The Bioethics Shared Resource promotes and ensures adherence to bioethical principles and addresses ethical considerations in relationships among our institutions and between institutions and communities. The Biostatistics Shared Resource maintains statistical support to all programs. The Partnership will continue to demonstrate its enhanced capability to conduct research on cancer health disparities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA118623-08
Application #
8550770
Study Section
Special Emphasis Panel (ZCA1-SRLB-Y (O1))
Program Officer
Ogunbiyi, Peter
Project Start
2005-09-28
Project End
2016-08-31
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
8
Fiscal Year
2013
Total Cost
$655,170
Indirect Cost
$352,657
Name
Tuskegee University
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
128214178
City
Tuskegee
State
AL
Country
United States
Zip Code
36088
Karthikeyan, Chandrabose; Lee, Crystal; Moore, Joshua et al. (2015) IND-2, a pyrimido[1?,2?:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells. Bioorg Med Chem 23:602-11
Samuel, Temesgen; Fadlalla, Khalda; Gales, Dominique N et al. (2014) Variable NF-?B pathway responses in colon cancer cells treated with chemotherapeutic drugs. BMC Cancer 14:599
Jones, Jacqueline; Wang, Honghe; Karanam, Balasubramanyam et al. (2014) Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas. Clin Exp Metastasis 31:497-510
Theodore, Shaniece C; Davis, Melissa; Zhao, Fu et al. (2014) MicroRNA profiling of novel African American and Caucasian Prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase 1. Oncotarget 5:3512-25
Welch-White, Venus; Dawkins, Norma; Graham, Thomas et al. (2013) The impact of high fat diets on physiological changes in euthyroid and thyroid altered rats. Lipids Health Dis 12:100
Zhou, Jianjun; Feigenbaum, Lionel; Yee, Carole et al. (2013) Mouse prostate epithelial luminal cells lineage originate in the basal layer where the primitive stem/early progenitor cells reside: implications for identifying prostate cancer stem cells. Biomed Res Int 2013:913179
Otali, D; He, Q; Stockard, C R et al. (2013) Preservation of immunorecognition by transferring cells from 10% neutral buffered formalin to 70% ethanol. Biotech Histochem 88:170-80
Woubit, Abdela; Yehualaeshet, Teshome; Roberts, Sherrelle et al. (2013) Customizable PCR-microplate array for differential identification of multiple pathogens. J Food Prot 76:1948-57
Wang, Honghe; Jones, Jacqueline; Turner, Timothy et al. (2012) Clinical and biological significance of KISS1 expression in prostate cancer. Am J Pathol 180:1170-8
Zhou, Jianjun; Wang, Honghe; Cannon, Virginetta et al. (2011) Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells. Mol Cancer 10:112

Showing the most recent 10 out of 16 publications